CL2019001623A1 - Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor. - Google Patents
Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor.Info
- Publication number
- CL2019001623A1 CL2019001623A1 CL2019001623A CL2019001623A CL2019001623A1 CL 2019001623 A1 CL2019001623 A1 CL 2019001623A1 CL 2019001623 A CL2019001623 A CL 2019001623A CL 2019001623 A CL2019001623 A CL 2019001623A CL 2019001623 A1 CL2019001623 A1 CL 2019001623A1
- Authority
- CL
- Chile
- Prior art keywords
- prevent
- relieve
- carbamate compound
- tremor syndrome
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCIÓN SE RELACIONA A UN USO DE UNA COMPOSICIÓN FARMACÉUTICA QUE INCLUYE UN COMPUESTO DE CARBAMATO DE LA FÓRMULA QUÍMICA 1 Y SE ADMINISTRA PARA PREVENIR, ALIVIAR O TRATAR TEMBLORES O EL SÍNDROME DE TEMBLOR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160170225 | 2016-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019001623A1 true CL2019001623A1 (es) | 2019-08-23 |
Family
ID=62558966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019001623A CL2019001623A1 (es) | 2016-12-14 | 2019-06-12 | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor. |
Country Status (13)
Country | Link |
---|---|
US (1) | US11033531B2 (es) |
EP (1) | EP3556364A4 (es) |
JP (1) | JP7086076B2 (es) |
KR (1) | KR102635941B1 (es) |
CN (1) | CN110267657B (es) |
AU (1) | AU2017374459B2 (es) |
BR (1) | BR112019012000A2 (es) |
CA (1) | CA3046300A1 (es) |
CL (1) | CL2019001623A1 (es) |
IL (1) | IL267191B2 (es) |
MX (1) | MX2019006941A (es) |
WO (1) | WO2018111009A1 (es) |
ZA (1) | ZA201903749B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
BR112021005193A2 (pt) * | 2018-09-21 | 2021-06-08 | Sk Biopharmaceuticals Co., Ltd. | medicamento e combinação para a prevenção, alívio ou tratamento de transtorno de estresse agudo ou transtorno de estresse pós-traumático, e, medicamento para a prevenção, alívio ou tratamento de sintoma de transtorno de estresse pós-traumático |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE369130T1 (de) * | 2001-02-27 | 2007-08-15 | Ortho Mcneil Pharm Inc | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen |
JP2007530694A (ja) | 2004-03-29 | 2007-11-01 | メルク エンド カムパニー インコーポレーテッド | ナトリウムチャネル遮断薬としてのビアリール置換ピラジノン |
US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
CN101657194B (zh) * | 2007-03-05 | 2013-10-23 | Indus生物技术私人有限公司 | 包含葫芦巴碱和4-羟基异亮氨酸的药物组合物及其方法 |
PL2445890T3 (pl) | 2009-06-22 | 2016-02-29 | Sk Biopharmaceuticals Co Ltd | Sposób wytwarzania estru (R)-1-arylo-2-tetrazoliloetylowego kwasu karbaminowego |
US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
KR101717872B1 (ko) | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물 |
KR102489052B1 (ko) | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 CA CA3046300A patent/CA3046300A1/en active Pending
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko unknown
- 2017-12-14 BR BR112019012000-9A patent/BR112019012000A2/pt active Search and Examination
- 2017-12-14 EP EP17880232.8A patent/EP3556364A4/en active Pending
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active IP Right Grant
- 2017-12-14 MX MX2019006941A patent/MX2019006941A/es unknown
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR102635941B1 (ko) | 2024-02-13 |
AU2017374459A1 (en) | 2019-07-04 |
WO2018111009A1 (ko) | 2018-06-21 |
JP7086076B2 (ja) | 2022-06-17 |
IL267191A (es) | 2019-07-31 |
AU2017374459B2 (en) | 2023-04-27 |
US11033531B2 (en) | 2021-06-15 |
CN110267657B (zh) | 2022-12-13 |
MX2019006941A (es) | 2019-09-06 |
CN110267657A (zh) | 2019-09-20 |
EP3556364A1 (en) | 2019-10-23 |
CA3046300A1 (en) | 2018-06-21 |
ZA201903749B (en) | 2022-01-26 |
RU2019121914A3 (es) | 2021-04-21 |
RU2019121914A (ru) | 2021-01-15 |
EP3556364A4 (en) | 2020-06-17 |
JP2020502137A (ja) | 2020-01-23 |
US20190336481A1 (en) | 2019-11-07 |
IL267191B1 (en) | 2023-01-01 |
KR20190087573A (ko) | 2019-07-24 |
BR112019012000A2 (pt) | 2019-10-29 |
IL267191B2 (en) | 2023-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018002009A1 (es) | Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras. | |
DOP2019000117A (es) | Nuevos derivados de quinolina | |
CO2017001994A2 (es) | Compuestos activos hacia bromodominios | |
UY37789A (es) | Nuevos derivados de azaquinolina | |
BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
UY37831A (es) | Nuevos derivados de quinolina | |
SA518400356B1 (ar) | مثبطات الأرجيناز واستخداماتها العلاجية | |
BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
MY192703A (en) | Compositions containing tucaresol or its analogs | |
BR112018072539A2 (pt) | composições de epinefrina de administração aumentada | |
DOP2021000017A (es) | Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar cánceres que incluyen los mismos | |
AR102973A1 (es) | Uso del compuesto 3,5-dihidroxi-4-isopropil-trans-estilbeno para la preparación de una composición farmacéutica, dicho compuesto y composición farmacéutica que lo comprende | |
EA201991580A1 (ru) | Пиримидиновое соединение и его фармацевтическое применение | |
BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112022008294A2 (pt) | Composições de profármaco e métodos de tratamento | |
CL2018003431A1 (es) | Tratamiento de la enfermedad de parkinson. | |
BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
BR112017022158A2 (pt) | compostos, composições farmacêuticas e uso de um composto | |
PE20161385A1 (es) | Formulacion inmunosupresora | |
AR094707A1 (es) | Compuesto de quinazolin-4-amina, composición farmacéutica que lo comprende y su uso para el tratamiento de una enfermedad mediada por la quinasa rip2 | |
SV2018005702A (es) | Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer | |
CL2019001618A1 (es) | Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar. | |
CL2019001623A1 (es) | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor. | |
MX2021001612A (es) | Compuestos utiles en terapia del vih. | |
BR112018073553A2 (pt) | medicamento e composição farmacêutica para a prevenção ou tratamento de fibromialgia ou sintomas funcionais associados com fibromialgia, método para prevenir ou tratar fibromialgia ou sintomas funcionais associados com fibromialgia em um indivíduo, e, uso de um composto carbamato. |